FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017201029> ?p ?o ?g. }

• W2017201029 endingPage "2841" @default.
• W2017201029 startingPage "2835" @default.
• W2017201029 abstract "Glucagon-like peptide 1 (GLP-1) is an insulinotropic gut hormone that, when given exogenously, may be a useful agent in the treatment of type 2 diabetes. We conducted a 3-month trial to determine the efficacy and safety of GLP-1 in elderly diabetic patients.A total of 16 patients with type 2 diabetes who were being treated with oral hypoglycemic agents were enrolled. Eight patients (aged 75 +/- 2 years, BMI 27 +/- 1 kg/m(2)) remained on usual glucose-lowering therapy and eight patients (aged 73 +/- 1 years, BMI 27 +/- 1 kg/m(2)), after discontinuing hypoglycemic medications, received GLP-1 delivered by continuous subcutaneous infusion for 12 weeks. The maximum dose was 120 pmol x kg(-1). h(-1). Patients recorded their capillary blood glucose (CBG) levels (four times per day, 3 days per week) and whenever they perceived hypoglycemic symptoms. The primary end points were HbA(1c) and CBG determinations. Additionally, changes in beta-cell sensitivity to glucose, peripheral tissue sensitivity to insulin, and changes in plasma ghrelin levels were examined.HbA(1c) levels (7.1%) and body weight were equally maintained in both groups. The usual treatment group had a total of 87 CBG measurements of <or=3.6 mmol/l during the study, and only 1 such measurement (3.5 mmol/l) was recorded in the GLP-1 group. Infusion of GLP-1 enhanced glucose-induced insulin secretion (pre: 119 +/- 21; post: 202 +/- 51 pmol/l; P < 0.05) and insulin-mediated glucose disposal (pre: 29.8 +/- 3.3; post: 35.9 +/- 2.3 micromol x kg(-1 x min(-1); P < 0.01). No effect of GLP-1 treatment was seen on the fasting plasma ghrelin levels. Although plasma ghrelin levels decreased during both portions of the clamp, a drug effect was not present.A GLP-1 compound is a promising therapeutic option for elderly diabetic patients." @default.
• W2017201029 created "2016-06-24" @default.
• W2017201029 creator A5000777749 @default.
• W2017201029 creator A5007270622 @default.
• W2017201029 creator A5014750217 @default.
• W2017201029 creator A5034913449 @default.
• W2017201029 creator A5046238445 @default.
• W2017201029 creator A5056649584 @default.
• W2017201029 date "2003-10-01" @default.
• W2017201029 modified "2023-09-27" @default.
• W2017201029 title "Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes" @default.
• W2017201029 cites W1748571508 @default.
• W2017201029 cites W1905803407 @default.
• W2017201029 cites W1975756049 @default.
• W2017201029 cites W1980130009 @default.
• W2017201029 cites W2006984980 @default.
• W2017201029 cites W2017518223 @default.
• W2017201029 cites W2056934377 @default.
• W2017201029 cites W2073099528 @default.
• W2017201029 cites W2073996229 @default.
• W2017201029 cites W2074956966 @default.
• W2017201029 cites W2089304685 @default.
• W2017201029 cites W2092745778 @default.
• W2017201029 cites W2096716906 @default.
• W2017201029 cites W2103960782 @default.
• W2017201029 cites W2122879720 @default.
• W2017201029 cites W2139538720 @default.
• W2017201029 cites W2140137473 @default.
• W2017201029 cites W2142877036 @default.
• W2017201029 cites W2143014102 @default.
• W2017201029 cites W2146400000 @default.
• W2017201029 cites W2156374993 @default.
• W2017201029 cites W2158822657 @default.
• W2017201029 cites W2161075296 @default.
• W2017201029 cites W2168588540 @default.
• W2017201029 cites W2335958328 @default.
• W2017201029 cites W2337454357 @default.
• W2017201029 cites W4211101627 @default.
• W2017201029 cites W4235989887 @default.
• W2017201029 cites W4239656478 @default.
• W2017201029 cites W4250843774 @default.
• W2017201029 cites W3141782761 @default.
• W2017201029 doi "https://doi.org/10.2337/diacare.26.10.2835" @default.
• W2017201029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14514588" @default.
• W2017201029 hasPublicationYear "2003" @default.
• W2017201029 type Work @default.
• W2017201029 sameAs 2017201029 @default.
• W2017201029 citedByCount "96" @default.
• W2017201029 countsByYear W20172010292012 @default.
• W2017201029 countsByYear W20172010292013 @default.
• W2017201029 countsByYear W20172010292014 @default.
• W2017201029 countsByYear W20172010292016 @default.
• W2017201029 countsByYear W20172010292017 @default.
• W2017201029 countsByYear W20172010292018 @default.
• W2017201029 countsByYear W20172010292019 @default.
• W2017201029 countsByYear W20172010292020 @default.
• W2017201029 countsByYear W20172010292021 @default.
• W2017201029 crossrefType "journal-article" @default.
• W2017201029 hasAuthorship W2017201029A5000777749 @default.
• W2017201029 hasAuthorship W2017201029A5007270622 @default.
• W2017201029 hasAuthorship W2017201029A5014750217 @default.
• W2017201029 hasAuthorship W2017201029A5034913449 @default.
• W2017201029 hasAuthorship W2017201029A5046238445 @default.
• W2017201029 hasAuthorship W2017201029A5056649584 @default.
• W2017201029 hasBestOaLocation W20172010291 @default.
• W2017201029 hasConcept C126322002 @default.
• W2017201029 hasConcept C134018914 @default.
• W2017201029 hasConcept C2776398474 @default.
• W2017201029 hasConcept C2777180221 @default.
• W2017201029 hasConcept C2778563252 @default.
• W2017201029 hasConcept C2779306644 @default.
• W2017201029 hasConcept C2779357093 @default.
• W2017201029 hasConcept C555293320 @default.
• W2017201029 hasConcept C71315377 @default.
• W2017201029 hasConcept C71924100 @default.
• W2017201029 hasConceptScore W2017201029C126322002 @default.
• W2017201029 hasConceptScore W2017201029C134018914 @default.
• W2017201029 hasConceptScore W2017201029C2776398474 @default.
• W2017201029 hasConceptScore W2017201029C2777180221 @default.
• W2017201029 hasConceptScore W2017201029C2778563252 @default.
• W2017201029 hasConceptScore W2017201029C2779306644 @default.
• W2017201029 hasConceptScore W2017201029C2779357093 @default.
• W2017201029 hasConceptScore W2017201029C555293320 @default.
• W2017201029 hasConceptScore W2017201029C71315377 @default.
• W2017201029 hasConceptScore W2017201029C71924100 @default.
• W2017201029 hasIssue "10" @default.
• W2017201029 hasLocation W20172010291 @default.
• W2017201029 hasLocation W20172010292 @default.
• W2017201029 hasOpenAccess W2017201029 @default.
• W2017201029 hasPrimaryLocation W20172010291 @default.
• W2017201029 hasRelatedWork W1981579062 @default.
• W2017201029 hasRelatedWork W2001044066 @default.
• W2017201029 hasRelatedWork W2029049751 @default.
• W2017201029 hasRelatedWork W2048352852 @default.
• W2017201029 hasRelatedWork W2086036309 @default.
• W2017201029 hasRelatedWork W2087297204 @default.
• W2017201029 hasRelatedWork W2097857221 @default.
• W2017201029 hasRelatedWork W2140259351 @default.

• next